Damora Therapeutics Inc.
DMRA | NASDAQ
$22.20
-$0.65 (-2.84%)
Sep 22, 2026, 2:33 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -0.15 | -0.25 | -0.50 | -0.47 | -1.48 | -9.07 |
PEG Ratio | 0 | 0.01 | 0.01 | -0.03 | -0.03 | 0.55 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0.13 | 0.37 | 0.59 | 0.47 | 0.65 | 1.91 |
P/FCF Ratio | -4.66 | -0.29 | -0.52 | -0.68 | -1.46 | -8.27 |
P/OCF Ratio | -4.66 | -0.29 | -0.52 | -0.68 | -1.46 | -8.27 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0 | 0.10 | 0.01 | 0.01 | 0.01 | 0.01 |
Quick Ratio | 12.98 | 14.07 | 6.31 | 5.75 | 24.23 | 30.42 |
Current Ratio | 12.98 | 14.07 | 6.31 | 5.75 | 24.23 | 30.42 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -87.29% | -148.15% | -118.61% | -99.79% | -44.15% | -21.05% |
Return on Assets | -80.54% | -125.14% | -100.32% | -84.20% | -42.34% | -20.30% |
Return on Invested Capital | -87.69% | -105.96% | -111.90% | -97.84% | -44.23% | -20.21% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove DMRA